Report Detail
Global Implantable Neurostimulation Devices Market Growth 2019-2024
- RnM3002030 |
- 22 February, 2019 |
- Global |
- 135 Pages |
- LPI(LP Information) |
- Other
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
North America region is the largest supplier of implantable neurostimulation devices, with a production market share nearly 82% in 2016. Europe is the second largest supplier of implantable neurostimulation devices, enjoying production market share nearly 12% in 2016.
North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Implantable Neurostimulation Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Implantable Neurostimulation Devices business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Neurostimulation Devices market by product type, application, key manufacturers and key regions and countries.
This study considers the Implantable Neurostimulation Devices value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pain Management
Parkinson's Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Boston Scientific
St. Jude Medical (Abbott)
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Implantable Neurostimulation Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Implantable Neurostimulation Devices market by identifying its various subsegments.
Focuses on the key global Implantable Neurostimulation Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Implantable Neurostimulation Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Implantable Neurostimulation Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Implantable Neurostimulation Devices Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Implantable Neurostimulation Devices Consumption 2014-2024
- 2.1.2 Implantable Neurostimulation Devices Consumption CAGR by Region
- 2.2 Implantable Neurostimulation Devices Segment by Type
- 2.2.1 Spinal Cord Stimulation (SCS)
- 2.2.2 Gastric Electric Stimulation (GES)
- 2.2.3 Deep Brain Stimulation (DBS)
- 2.2.4 Sacral Nerve Stimulation (SNS)
- 2.2.5 Vagus Nerve Stimulation (VNS)
- 2.2.6 Other
- 2.3 Implantable Neurostimulation Devices Consumption by Type
- 2.3.1 Global Implantable Neurostimulation Devices Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Implantable Neurostimulation Devices Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Implantable Neurostimulation Devices Sale Price by Type (2014-2019)
- 2.4 Implantable Neurostimulation Devices Segment by Application
- 2.4.1 Pain Management
- 2.4.2 Parkinson's Disease
- 2.4.3 Urinary and Fecal Incontinence
- 2.4.4 Epilepsy
- 2.4.5 Gastroparesis
- 2.4.6 Other
- 2.5 Implantable Neurostimulation Devices Consumption by Application
- 2.5.1 Global Implantable Neurostimulation Devices Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Implantable Neurostimulation Devices Value and Market Share by Application (2014-2019)
- 2.5.3 Global Implantable Neurostimulation Devices Sale Price by Application (2014-2019)
3 Global Implantable Neurostimulation Devices by Players
- 3.1 Global Implantable Neurostimulation Devices Sales Market Share by Players
- 3.1.1 Global Implantable Neurostimulation Devices Sales by Players (2017-2019)
- 3.1.2 Global Implantable Neurostimulation Devices Sales Market Share by Players (2017-2019)
- 3.2 Global Implantable Neurostimulation Devices Revenue Market Share by Players
- 3.2.1 Global Implantable Neurostimulation Devices Revenue by Players (2017-2019)
- 3.2.2 Global Implantable Neurostimulation Devices Revenue Market Share by Players (2017-2019)
- 3.3 Global Implantable Neurostimulation Devices Sale Price by Players
- 3.4 Global Implantable Neurostimulation Devices Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Implantable Neurostimulation Devices Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Implantable Neurostimulation Devices Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Implantable Neurostimulation Devices by Regions
- 4.1 Implantable Neurostimulation Devices by Regions
- 4.1.1 Global Implantable Neurostimulation Devices Consumption by Regions
- 4.1.2 Global Implantable Neurostimulation Devices Value by Regions
- 4.2 Americas Implantable Neurostimulation Devices Consumption Growth
- 4.3 APAC Implantable Neurostimulation Devices Consumption Growth
- 4.4 Europe Implantable Neurostimulation Devices Consumption Growth
- 4.5 Middle East & Africa Implantable Neurostimulation Devices Consumption Growth
5 Americas
- 5.1 Americas Implantable Neurostimulation Devices Consumption by Countries
- 5.1.1 Americas Implantable Neurostimulation Devices Consumption by Countries (2014-2019)
- 5.1.2 Americas Implantable Neurostimulation Devices Value by Countries (2014-2019)
- 5.2 Americas Implantable Neurostimulation Devices Consumption by Type
- 5.3 Americas Implantable Neurostimulation Devices Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Implantable Neurostimulation Devices Consumption by Countries
- 6.1.1 APAC Implantable Neurostimulation Devices Consumption by Countries (2014-2019)
- 6.1.2 APAC Implantable Neurostimulation Devices Value by Countries (2014-2019)
- 6.2 APAC Implantable Neurostimulation Devices Consumption by Type
- 6.3 APAC Implantable Neurostimulation Devices Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Implantable Neurostimulation Devices by Countries
- 7.1.1 Europe Implantable Neurostimulation Devices Consumption by Countries (2014-2019)
- 7.1.2 Europe Implantable Neurostimulation Devices Value by Countries (2014-2019)
- 7.2 Europe Implantable Neurostimulation Devices Consumption by Type
- 7.3 Europe Implantable Neurostimulation Devices Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Implantable Neurostimulation Devices by Countries
- 8.1.1 Middle East & Africa Implantable Neurostimulation Devices Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Implantable Neurostimulation Devices Value by Countries (2014-2019)
- 8.2 Middle East & Africa Implantable Neurostimulation Devices Consumption by Type
- 8.3 Middle East & Africa Implantable Neurostimulation Devices Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Implantable Neurostimulation Devices Distributors
- 10.3 Implantable Neurostimulation Devices Customer
11 Global Implantable Neurostimulation Devices Market Forecast
- 11.1 Global Implantable Neurostimulation Devices Consumption Forecast (2019-2024)
- 11.2 Global Implantable Neurostimulation Devices Forecast by Regions
- 11.2.1 Global Implantable Neurostimulation Devices Forecast by Regions (2019-2024)
- 11.2.2 Global Implantable Neurostimulation Devices Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Implantable Neurostimulation Devices Forecast by Type
- 11.8 Global Implantable Neurostimulation Devices Forecast by Application
12 Key Players Analysis
- 12.1 Medtronic
- 12.1.1 Company Details
- 12.1.2 Implantable Neurostimulation Devices Product Offered
- 12.1.3 Medtronic Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Medtronic News
- 12.2 Boston Scientific
- 12.2.1 Company Details
- 12.2.2 Implantable Neurostimulation Devices Product Offered
- 12.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Boston Scientific News
- 12.3 St. Jude Medical (Abbott)
- 12.3.1 Company Details
- 12.3.2 Implantable Neurostimulation Devices Product Offered
- 12.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 St. Jude Medical (Abbott) News
- 12.4 LivaNova
- 12.4.1 Company Details
- 12.4.2 Implantable Neurostimulation Devices Product Offered
- 12.4.3 LivaNova Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 LivaNova News
- 12.5 Nevro
- 12.5.1 Company Details
- 12.5.2 Implantable Neurostimulation Devices Product Offered
- 12.5.3 Nevro Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Nevro News
- 12.6 NeuroPace
- 12.6.1 Company Details
- 12.6.2 Implantable Neurostimulation Devices Product Offered
- 12.6.3 NeuroPace Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 NeuroPace News
- 12.7 Beijing Pins
- 12.7.1 Company Details
- 12.7.2 Implantable Neurostimulation Devices Product Offered
- 12.7.3 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Beijing Pins News
- 12.8 Synapse Biomedical
- 12.8.1 Company Details
- 12.8.2 Implantable Neurostimulation Devices Product Offered
- 12.8.3 Synapse Biomedical Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Synapse Biomedical News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Implantable Neurostimulation Devices . Industry analysis & Market Report on Implantable Neurostimulation Devices is a syndicated market report, published as Global Implantable Neurostimulation Devices Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Implantable Neurostimulation Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
